NCT06999499Not yet recruiting
Development of an Aid to Melanoma Detection Using Artificial Intelligence Algorithms Based on Images From the VECTRA 3D System.
Development of Artificial Intelligence Algorithms to Help Detect Potential Melanomas, Using Images From the VECTRA 3D Whole Body 360 Imaging System, a 3D Whole-body Skin Scanner.
Source: ClinicalTrials.gov · Last updated 28 Oct 2026
Brief summary (registry, in English)
The background to this research is that frequent medical screening of the general population for melanoma is not feasible. The real challenge of this project is to develop an automatic process for detecting any potential melanoma. To this end, the project aims to design an algorithm to build a novel diagnostic aid that makes use of the similarity and disparity of pigmented lesions in the same patient. To achieve this, we need to obtain and structure a large database of images grouping all pigmented lesions per patient according to their similarities as perceived by dermatologists.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 1000 (estimated)
- First submitted
- 20 May 2025
- Start date
- 1 Jan 2027
- Primary completion date
- 1 Mar 2028
- Lead sponsor
- Assistance Publique Hopitaux De Marseille
- Diseases
- Melanoma
- NCT number
- NCT06999499
What you commit to
- Study type: Interventional
- Planned participants: 1000
- From 1 Jan 2027 to the primary completion date, 1 Mar 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with chronic inflammatory skin diseases
Other
- Patients with phototype V
- Claustrophobic patients
- Patients who are bedridden or handicapped
- Patients who are excluded from another research protocol at the time of collection of the non-objection.
- Patients covered by articles L1121-5 to 1121-8 of the French Public Health Code (minors, adults under guardianship or trusteeship, patients deprived of their liberty, pregnant or breast-feeding women),
- Any other reason which, in the investigator's opinion, could interfere with the evaluation of the research objectives.
Who the study is looking for
- Male or female aged 18 and over
- Patient with more than 15 nevi (moles) of various phototypes (I to III)
- Patient who has received information about the study and has not expressed any opposition
- Patient who is a beneficiary or entitled person under a social security scheme
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hôpital de la Conception Coordinator of this site? Confirm its status | Marseille | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.